Mika Aoyagi-Scharber in

Mika Aoyagi-Scharber

Energizer · DISC type I
Vice President, Translational Research, Program & Portfolio Management at Ultragenyx
📍 San Francisco, California, United States

Mika Aoyagi-Scharber is the Vice President of Translational Research at Ultragenyx, leading program and portfolio management. Her career includes extensive experience in scientific strategy at BioMarin. She holds a Ph. D. from Scripps Research and is described by colleagues as inquisitive, thorough, and hard-working.

While specific personal hobbies are not public, she maintains a strong connection to her alma maters, the University of Minnesota and Scripps Research, indicating a passion for the academic and scientific communities that shaped her career.

She is a co-inventor on a patent for compositions and methods for treating the rare Glycogen Storage Disease Type III.

Read the full overview →
Experience
21 Years
Current Role
Vice President, Translational Research, Program & Portfolio Management
Job Level
Senior
Location
San Francisco, California, United States
Personality Overview

How Mika shows up

Imaginative
Informal
Believer

They are friendly, approachable and love to make new connections. Unlike C or D types, they are vocal with their opinions but not so much with their questions. They are not always early adopters but can be pursuaded by leveraging strong relationships.

Priorities

Topics Mika cares about

Rare Disease Therapeutics
Her career at both Ultragenyx and BioMarin, along with a patent for treating Glycogen Storage Disease Type III, shows a deep commitment to developing therapies for rare disorders.
Translational Research
Her executive title and focus involve bridging the gap between foundational scientific discoveries and creating tangible new treatments for patients.
+4 more topics Login to view topics
Career

Work history

9-2024
Vice President, Translational Research, Program & Portfolio Management
Ultragenyx
4-2021 - 8-2024
Executive Director, Translational Research, Program & Portfolio Management
Ultragenyx
3-2021 - 4-2021
Executive Director, Scientific Strategy & Discovery Portfolio
BioMarin Pharmaceutical Inc.
4-2018 - 2-2021
Senior Director, Scientific Strategy & Discovery Portfolio
BioMarin Pharmaceutical Inc.
11-2017 - 3-2018
Director, Scientific Strategy & Discovery Portfolio
BioMarin Pharmaceutical Inc.
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1998 - 2004
Ph.D.
Scripps Research
1993 - 1997
B.S.
University of Minnesota
Social presence
in
Behavioral profile

DISC profile (public)

I

Influence (I)

Influence (I) reflects the degree to which a person prefers to work by influencing or persuading others. Those scoring high tend to be people oriented, motivated by social recognition and building relationships.

Other Ultragenyx Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Mika. Free, 10 seconds.